✓
Anne L. Peters, MD
Endocrinologist · Professor of Medicine · Diabetes Care and Technology
Anne L. Peters, MD, is a Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes Programs. Her work spans type 1 and type 2 diabetes, diabetes technology, insulin therapy, continuous glucose monitoring and efforts to improve access to care across different communities.
About Dr. Peters
Her career combines specialist diabetes care, clinical research, guideline development, professional education and programs designed to improve outcomes for underserved populations.
Clinical leadership
Dr. Peters is Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes Programs.
Research and public impact
Her work includes new approaches to diabetes diagnosis and treatment, diabetes technology, systems of care and improved access for people across the socioeconomic spectrum.
Areas of expertise
ClearMed Journal uses the generic ingredient name empagliflozin when discussing medicine commonly known by the Jardiance brand.
Type 2 diabetes
Diagnosis, treatment planning, glucose management and long-term risk reduction.
Empagliflozin
Educational context for the SGLT2 inhibitor empagliflozin in type 2 diabetes care.
Continuous glucose monitoring
CGM interpretation, practical use, access and integration into clinical care.
Insulin therapy
Insulin treatment, delivery systems, safety and patient-centred management.
Diabetes technology
Insulin pumps, connected devices, monitoring systems and technology-access issues.
Health equity
Programs and research focused on improving diabetes outcomes in underserved communities.
Training and career
Doctor of Medicine
University of Chicago Pritzker School of Medicine
Internal medicine residency
Stanford University
Endocrinology fellowship
Cedars-Sinai Medical Center
Professor of Medicine
Keck School of Medicine of USC · Clinical Scholar
Selected professional focus
- ✓Type 1 and type 2 diabetes treatment
- ✓Continuous glucose monitoring and insulin pumps
- ✓Diabetes devices and technology safety
- ✓Clinical systems designed to improve diabetes outcomes
- ✓Access to care and health disparities
Professional contribution
Selected recognition
- ✓2021 Endocrine Society Outstanding Public Service Laureate Award
- ✓American Diabetes Association Outstanding Physician Clinician Award
- ✓Bernardo Alberto Houssay Award, National Minority Quality Forum
- ✓Fellow of the American College of Physicians
- ✓Contributor to diabetes guideline and technology committees
Professional sources
Readers can use these records to confirm the profile information and explore published work.
Profile review & publication
Profile information reviewed and published by ClearMed Journal
Professional titles, training, expertise, roles and linked records are presented using the profile information and professional sources maintained for this expert.
Professional information is organised against linked records.
Readers can open professional, academic or scholarly references.
Writing and medical-review relationships are displayed separately.
Profiles can be revised when material professional information changes.
Medical information notice: This profile and related articles provide general educational information and do not replace individual diagnosis, treatment or advice from a licensed healthcare professional. Empagliflozin and other prescription medicines should be used only under appropriate medical supervision.



